Maria Stangou Selected Research

3- ((5- (6- methylpyridin- 2- yl)- 4- (quinoxalin- 6- yl)- 1H- imidazol- 2- yl)methyl)benzamide

1/2020

Is there long-term value of pathology scoring in immunoglobulin A nephropathy? A validation study of the Oxford Classification for IgA Nephropathy (VALIGA) update.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Maria Stangou Research Topics

Disease

13	IGA Glomerulonephritis (IGA Nephropathy) 02/2024 - 07/2004
9	Proteinuria 02/2024 - 01/2005
7	Glomerulonephritis 02/2024 - 02/2010
6	Chronic Kidney Failure (Chronic Renal Failure) 02/2024 - 02/2021
5	Chronic Renal Insufficiency 02/2024 - 08/2022
4	Nephrotic Syndrome (Syndrome, Nephrotic) 09/2023 - 07/2017
4	Fibrosis (Cirrhosis) 01/2020 - 01/2005
3	Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis 02/2024 - 01/2021
3	COVID-19 10/2023 - 08/2022
3	Atrophy 01/2020 - 01/2008
3	Focal Segmental Glomerulosclerosis (Glomerulosclerosis, Focal) 07/2017 - 01/2008
2	Nephritis 09/2023 - 01/2011
2	Kidney Diseases (Kidney Disease) 03/2023 - 01/2023
2	Hypovolemia 01/2023 - 01/2011
2	Renal Insufficiency (Renal Failure) 09/2022 - 01/2020
2	Lipoid Nephrosis (Glomerulonephritis, Minimal Change) 01/2022 - 07/2017
2	Segmental glomerulosclerosis 01/2020 - 01/2019
2	Membranous Glomerulonephritis (Membranous Nephropathy) 06/2019 - 01/2019
1	Stroke (Strokes) 07/2023
1	Atrial Fibrillation 07/2023
1	Type 2 Diabetes Mellitus (MODY) 03/2023
1	Carotid Artery Diseases 03/2023
1	Cardiovascular Diseases (Cardiovascular Disease) 03/2023
1	Paraproteinemias (Monoclonal Gammopathy) 03/2023
1	Gitelman Syndrome 01/2023
1	Oliguria 01/2023
1	Chronic Tubulointerstitial Nephropathy 01/2023
1	Constipation 01/2023
1	Hyperaldosteronism (Conn Syndrome) 01/2023
1	Hypokalemia 01/2023
1	Hyponatremia 01/2023
1	Fatigue 01/2023
1	Anorexia 01/2023
1	Thyroid Diseases (Thyroid Disease) 09/2022
1	Thyroiditis 09/2022
1	Microscopic Polyangiitis 09/2022
1	Granulomatosis with Polyangiitis (Wegener's Granulomatosis) 09/2022
1	Churg-Strauss Syndrome (Allergic Angiitis) 09/2022
1	Infections 08/2022
1	Chronic Progressive Multiple Sclerosis 01/2022
1	Interstitial Nephritis (Tubulointerstitial Nephritis) 01/2022
1	Relapsing-Remitting Multiple Sclerosis 01/2022
1	Vascular Calcification 10/2021
1	Arteriovenous Fistula 10/2021

Drug/Important Bio-Agent (IBA)

6	CreatinineIBA 09/2023 - 01/2005
5	Immunoglobulin A (IgA)IBA 02/2024 - 02/2010
5	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 02/2024 - 01/2005
3	Adrenal Cortex Hormones (Corticosteroids)IBA 02/2024 - 01/2005
3	BNT162 VaccineIBA 10/2023 - 01/2022
3	Proteins (Proteins, Gene)FDA Link 09/2023 - 06/2011
3	Biomarkers (Surrogate Marker)IBA 01/2022 - 03/2016
3	SteroidsIBA 01/2022 - 06/2011
3	Azathioprine (Imuran)FDA LinkGeneric 02/2018 - 06/2011
3	CytokinesIBA 07/2017 - 09/2009
2	Uremic ToxinsIBA 09/2023 - 09/2022
2	Immunoglobulin M (IgM)IBA 03/2023 - 01/2022
2	SodiumIBA 03/2023 - 01/2023
2	Messenger RNA (mRNA)IBA 03/2023 - 01/2019
2	VaccinesIBA 01/2023 - 08/2022
2	Urea (Carbamide)FDA LinkGeneric 01/2023 - 09/2022
2	galactosyl-deficient IgA1IBA 05/2021 - 03/2016
2	Complement System Proteins (Complement)IBA 01/2021 - 01/2019
2	AutoantibodiesIBA 06/2019 - 02/2010
2	Interleukin-2 (IL2)IBA 07/2017 - 09/2013
1	Budesonide (Pulmicort)FDA LinkGeneric 02/2024
1	voclosporinIBA 09/2023
1	belimumabIBA 09/2023
1	AnnexinsIBA 03/2023
1	Sodium-Glucose Transporter 2 InhibitorsIBA 03/2023
1	LDL CholesterolIBA 03/2023
1	SymportersIBA 03/2023
1	Glucose (Dextrose)FDA LinkGeneric 03/2023
1	Neutralizing AntibodiesIBA 01/2023
1	Immunologic Factors (Immunomodulators)IBA 01/2023
1	Eplerenone (Inspra)FDA LinkGeneric 01/2023
1	PotassiumIBA 01/2023
1	mRNA VaccinesIBA 09/2022
1	trimethyloxamine (trimethylamine N-oxide)IBA 09/2022
1	IndicanIBA 09/2022
1	trimethylamineIBA 09/2022
1	OxidesIBA 09/2022
1	Sulfates (Sulfates, Inorganic)IBA 09/2022
1	ocrelizumabIBA 01/2022
1	Serum AlbuminIBA 01/2022
1	Immunoglobulin D (IgD)IBA 01/2022
1	Monoclonal AntibodiesIBA 01/2022
1	myasthenia gravis anti-skeletal muscle antibody (ASMA)IBA 10/2021
1	MicroRNAs (MicroRNA)IBA 05/2021
1	Complement Factor B (Factor B)IBA 01/2021
1	3- ((5- (6- methylpyridin- 2- yl)- 4- (quinoxalin- 6- yl)- 1H- imidazol- 2- yl)methyl)benzamideIBA 01/2020
1	ParaffinIBA 01/2020
1	Formaldehyde (Formol)FDA Link 01/2020

Therapy/Procedure

8	Renal Dialysis (Hemodialysis) 02/2024 - 10/2002
2	Aftercare (After-Treatment) 02/2024 - 01/2005
2	Continuous Ambulatory Peritoneal Dialysis (CAPD) 03/2023 - 02/2021
2	Kidney Transplantation 09/2022 - 08/2022
2	Therapeutics 01/2020 - 06/2002
1	Central Venous Catheters 07/2023
1	Peritoneal Dialysis 09/2022
1	Hemodiafiltration 01/2022